obesity

Showing 15 posts of 52 posts found.

slimming-2728331_960_720

One in 25 English children are severely obese by secondary school, study finds

May 29, 2018
Manufacturing and Production, Research and Development England, UK, childhood obesity, obesity, pharma

A new analysis of Public Health England figures by the Local Government Association (LGA) has revealed that one in 25 …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 25, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Cancer, Gielad, Novartis, brexit, obesity, pharma, top ten

It’s a special Firday here in Europe, as today marks the advent of the General Data Protection Regulation (GDPR), an …

obese-3011213_960_720

World heading towards 25% of total population being obese

May 23, 2018
Research and Development WHO, biotech, drugs, obesity, pharma, pharmaceutical

The latest global research paints a bleak picture of future global public health, predicting that almost a quarter of the …

sugar_tax

The UK sugar tax: A sweet or sour move?

May 3, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, obesity, pharma, sugar tax

Dr Daniel Bailey, Senior Lecturer in Health, Nutrition and Exercise at the University of Bedfordshire, discusses the benefits of the …

weight-2036971_960_720

UK rates of obesity increased by 92% over two decades

November 13, 2017
Research and Development, Sales and Marketing OECD, biotech, drugs, obesity, pharma, pharmaceutical

A recent report by the OECD shares concerns that the UK’s overall health looks set to face a crisis due …

weight-2036971_960_720

Childhood obesity increased 10-fold over last four decades

October 11, 2017
Research and Development biotech, drugs, obese, obesity, pharma, pharmaceutical

An analysis of childhood and teenage obesity levels around the world have revealed that the numbers who are considered dangerously …

energy-bar-snack-chocolate-bar-chocolate-candy-1636220

‘Hugely disturbing’ rise in UK children with type 2 diabetes, report finds

August 14, 2017
Medical Communications, Sales and Marketing childhood obesity, diabetes, healthcare, life sciences, obesity, pharma, pharmaceuticals

A report from the Royal College of Paediatrics and Child Health (RCPCH) has highlighted a “hugely disturbing” rise in cases …

FDA investigating intragastric obesity treatment linked to five deaths

August 14, 2017
Medical Communications, Sales and Marketing life sciences, medicine, obesity, pharma, pharmaceutical

The FDA has launched an investigation after five deaths thought to be caused by an obesity treatment surgery in which …

shutterstock_87495637

Drug combinations can boost weight loss, research finds

July 19, 2017
Research and Development biotech, drugs, healthcare, obesity, pharma, pharmaceuticals, weight loss

Researchers at the Perelman School of Medicine at the University of Pennsylvania have found that by combining specific hormone-based drugs …

MRI obese overweight

Novo Nordisk forms academic partnership with Washington Uni

November 4, 2015
Research and Development Novo Nordisk, diabetes, obesity

Novo Nordisk has launched a new research collaboration with researchers at the University of Washington, to develop new drugs for …

obesity

Innovative pipeline can transform obesity treatment, says GBI Research

October 8, 2015
Research and Development obesity

While the current obesity treatment market has a high level of unmet need, the therapeutic landscape could be transformed by …

body scan

Pfizer in metabolic disease push

September 11, 2015
Medical Communications, Research and Development AMRA, Pfizer, UK Biobank, med tech, metabolic disease, obesity

Pfizer has signed a research collaboration with a global medical health technology company, to investigate risk factors for metabolic conditions.  …

contrave

Takeda hits major snags with Contrave and Alisertib

May 14, 2015
Sales and Marketing Contrave, Takeda, alisertib, obesity, orexigen

Takeda is threatening to end its partnership with Orexigen to market the obesity drug Contrave, as allegations around its heart …

Novo image

Novo Nordisk obesity drug is launched in the US

April 23, 2015
Sales and Marketing Novo Nordisk, liraglutide, obesity, overweight, saxenda, world health organization

Novo Nordisk is rolling out its obesity drug Saxenda across the US for the treatment of obese adult patients. Saxanda …

Saxenda image

Novo Nordisk obesity drug gets EU approval

March 24, 2015
Sales and Marketing EMA, EU, FDA, Victoza, liraglutide, obesity, saxenda

Novo Nordisk’s obesity drug Saxenda has been approved by the European Commission for use across the EU. This approval follows …

Latest content